PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Geoffrey Shapiro, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT02022982
First received: December 23, 2013
Last updated: January 29, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)